Chemiluminescence Analyzer Market by Product, End-user, and Geography - Forecast and Analysis 2021-2025

The chemiluminescence analyzer market share is expected to increase by USD 5.31 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 9%.

This chemiluminescence analyzer market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers chemiluminescence analyzer market segmentation by product (benchtop CLA and floor-standing CLA), end-user (hospitals and diagnostic centers, research laboratories, pharma and biotech companies, and academic research centers), and geography (Europe, North America, APAC, and ROW). The chemiluminescence analyzer market report also offers information on several market vendors, including Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, Sysmex Corp., The Carlyle Group Inc., and Tosoh Corp. among others.

What will the Chemiluminescence Analyzer Market Size be During the Forecast Period?

Download Report Sample to Unlock the Chemiluminescence Analyzer Market Size for the Forecast Period and Other Important Statistics

 

Chemiluminescence Analyzer Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The increasing geriatric population is notably driving the chemiluminescence analyzer market growth, although factors such as lack of accessibility and affordability of diagnostic tests in developing countries may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the chemiluminescence analyzer industry. The holistic analysis of the drivers will help deduce end goals and refine marketing strategies to gain a competitive edge.

Key Chemiluminescence Analyzer Market Driver

The increasing geriatric population is one of the major drivers impacting the chemiluminescence analyzer market growth. Globally, there has been a rise in the elderly population. In 2018, the population of people aged 65 years and above accounted for 8.87% of the global population. Furthermore, there is a growing prevalence of both communicable diseases such as COVID-19, which is expected to accelerate the diagnosis and testing. Also, the probability of non-communicable diseases such as cancer, diabetes, cardiovascular disease, lung disease, cancer, and stroke increase with growing age, which drives the growth of the global chemiluminescence analyzer (CLA) market. Consequently, there is now a growing need associated with the global burden of disease to prevent, diagnose, and treat such chronic diseases. By 2030, the burden of non-communicable diseases in low and middle-income countries will be between 52% and 54%, while for communicable diseases, it will fall between 30% and 33%. In the case of the older population, non-communicable diseases account for approximately 85%-90% of the burden across countries and in all income groups. 

Key Chemiluminescence Analyzer Market Trend

Increasing growth potential in emerging economies is one of the major trends influencing the chemiluminescence analyzer market growth. The growing demand for improving patient outcomes through advanced screening and diagnosis of diseases, rising healthcare expenditure, increasing number of hospitals, and increasing incidence of lifestyle disease is encouraging vendors to establish themselves in developing economies such as India and China, which offer substantial market opportunities. The increasing number of raw material suppliers, relatively low labor costs, and the low cost of raw materials are the major factors attracting established vendors and new entrants to expand their presence in emerging economies. Developing countries such as China and India have the largely untapped market potential for cancer and diabetes product manufacturers. The healthcare industry, including hospitals and clinics in developing economies, is growing at a tremendous pace, owing to the ongoing demographic shifts and rising healthcare expenditure. 

Key Chemiluminescence Analyzer Market Challenge

The lack of accessibility and affordability of diagnostic tests in developing countries is one of the major challenges impeding the chemiluminescence analyzer market growth. High-quality diagnostic tests are easily available for various diseases in the majority of developed countries; however, they are neither affordable nor accessible in developing countries, where the disease burden is high. Management of disease by addressing symptoms is ineffective and increases the risk of antibiotic resistance. Therefore, evidence-based treatment is needed along with proper diagnostic testing for efficient disease management and developing therapies. Technology transfer and local production could be some possible strategies to address the various challenges affecting the diagnostics market in developing countries. However, the obstacles in the implementation of these practices have wide-reaching consequences and thus affect the overall well-being of the population in these countries. Pricing of diagnostic tests is a significant issue that vendors experience in countries such as India and China. The lack of a structured insurance program adds to the problem of pricing. 

This chemiluminescence analyzer market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the global chemiluminescence analyzer (CLA) market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the chemiluminescence analyzer market during the forecast period.

Who are the Major Chemiluminescence Analyzer Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

• Abbott Laboratories
• bioMerieux SA
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Siemens Healthineers AG
• Sysmex Corp.
• The Carlyle Group Inc.
• Tosoh Corp.

 

This statistical study of the chemiluminescence analyzer market encompasses successful business strategies deployed by the key vendors. The chemiluminescence analyzer market is fragmented and the vendors are deploying growth strategies such as R&D to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The chemiluminescence analyzer market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the leading companies' production, sustainability, and prospects.

Chemiluminescence Analyzer Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the chemiluminescence analyzer market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the healthcare equipment market includes the following core components:

• Inputs
• Inbound logistics
• Operations
• Outbound logistics
• Marketing and sales
• Service
• Support activities
• Innovation

The report has further elucidated other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Chemiluminescence Analyzer Market?

For more insights on the market share of various regions Request PDF Sample now!

35% of the market’s growth will originate from Europe during the forecast period. Germany and France are the key markets for chemiluminescence analyzers in Europe. Market growth in this region will be slower than the growth of the market in APAC, North America, and ROW.

The growing population in need of diagnostic procedures and country-specific programs that create awareness around the importance of precision medicine is one of the prime factors that will facilitate the chemiluminescence analyzer market growth in Europe over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, 

COVID Impact and Recovery Analysis

The Netherlands, the UK, Spain, Italy, France, and Germany were some of the countries severely affected by the COVID-19 pandemic in the region in 2020. For instance, according to the data stated by the European Centre for Disease Prevention and Control (ECDC), the total number of COVID-19 cases in Spain, Germany, and France increased from 28,572; 24,774; and 16,018, respectively, on March 23, 2020, to 298,9085; 2,288,545; and 3,337,048 respectively, on February 11, 2021. The lockdowns imposed in the region during the first few months of 2020 to contain the spread of COVID-19 resulted in the shutdown of various manufacturing plants, including the manufacturing units of laboratory equipment such as CLAs, in various countries in the region. This led to a decline in the production volume of CLAs in the region to a certain extent, especially during the first few months of 2020. However, the rise in the number of COVID-19 cases increased the demand for advanced diagnostic procedures in the region for effective diagnosis of COVID-19.

What are the Revenue-generating Product Segments in the Chemiluminescence Analyzer Market?

To gain further insights on the market contribution of various segments Request PDF Sample

The chemiluminescence analyzer market share growth in the benchtop CLA segment will be significant during the forecast period. Benchtop CLAs are analytical devices that require smaller space than floor-standing analyzers. These analyzers also enhance the capabilities of diagnostic labs by freeing up space in the lab to be utilized for other applications. The adoption of these analyzers is likely to be high in countries with higher disease prevalence, which have a consequent need for rapid analysis of a large number of samples at affordable costs. Therefore, the growth of the market segment is expected to be significant during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the chemiluminescence analyzer market size.

 

Chemiluminescence Analyzer Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 9%
Market growth 2021-2025	$ 5.31 billion
Market structure	Fragmented
YoY growth (%)	8.05
Regional analysis	Europe, North America, APAC, and ROW
Performing market contribution	Europe at 35%
Key consumer countries	US, UK, Canada, Germany, and France
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, Sysmex Corp., The Carlyle Group Inc., and Tosoh Corp.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Chemiluminescence Analyzer Market Report?

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive chemiluminescence analyzer market growth during the next five years
• Precise estimation of the chemiluminescence analyzer market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the chemiluminescence analyzer industry across Europe, North America, APAC, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of chemiluminescence analyzer market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch